Mahdavi Gorabi, A.; Banach, M.; Reiner, Ž.; Pirro, M.; Hajighasemi, S.; Johnston, T.P.; Sahebkar, A.
The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu. J. Clin. Med. 2019, 8, 1413.
https://doi.org/10.3390/jcm8091413
AMA Style
Mahdavi Gorabi A, Banach M, Reiner Ž, Pirro M, Hajighasemi S, Johnston TP, Sahebkar A.
The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu. Journal of Clinical Medicine. 2019; 8(9):1413.
https://doi.org/10.3390/jcm8091413
Chicago/Turabian Style
Mahdavi Gorabi, Armita, Maciej Banach, Željko Reiner, Matteo Pirro, Saeideh Hajighasemi, Thomas P. Johnston, and Amirhossein Sahebkar.
2019. "The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu" Journal of Clinical Medicine 8, no. 9: 1413.
https://doi.org/10.3390/jcm8091413
APA Style
Mahdavi Gorabi, A., Banach, M., Reiner, Ž., Pirro, M., Hajighasemi, S., Johnston, T. P., & Sahebkar, A.
(2019). The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu. Journal of Clinical Medicine, 8(9), 1413.
https://doi.org/10.3390/jcm8091413